Back to Search Start Over

Results of simulation of performance indicators for the oncological service when introducing innovative technologies for treatment of stage IV lung cancer

Authors :
O. V. Zelenova
N. A. Golubev
V. M. Danilov
S. A. Sterlikov
S. I. Аbramov
Yu. V. Mikhaylova
Source :
Tuberkulez i Bolezni Lëgkih, Vol 98, Iss 4, Pp 15-23 (2020)
Publication Year :
2020
Publisher :
NEW TERRA Publishing House, 2020.

Abstract

Malignant tumors of the trachea, bronchi, lungs represent a serious medical and social problem. Most cases of cancer of the trachea, bronchus, and lung are detected at stage IV, and therefore, to improve the survival of patients, a new treatment strategy is proposed based on modern data on mutagenesis and receptor status of tumor cells, which has a personalized approach for each specific case. To make managerial decisions about the introduction of innovative drugs, a forecast of expected results is required which should be improved indicators of the State Program On Healthcare Development. It has been found out that the transition to a new strategy for lung cancer chemotherapy will reduce mortality from malignant tumors by 1.2-0.7%, including lung cancer by 3.9%, as well as one-year case fatality by 3% for all malignant tumors, including 15% for lung cancer. At the same time, within 5 years after the introduction of the new strategy for lung cancer treatment, the indicator reflecting the proportion of patients with malignant tumors registered for 5 years or more is expected to decrease, which is related to specific parameters of the calculation method.The authors state that they have no conflict of interests.

Details

Language :
Russian
ISSN :
25421506 and 20751230
Volume :
98
Issue :
4
Database :
OpenAIRE
Journal :
Tuberkulez i Bolezni Lëgkih
Accession number :
edsair.doi.dedup.....0b4080a402f289234dc69b4d808c0930